EMEA-001264-PIP01-12-M02
Key facts
Invented name |
Spherox
|
Active substance |
spheroids of human autologous matrix-associated chondrocytes
|
Therapeutic area |
Other
|
Decision number |
P/0161/2018
|
PIP number |
EMEA-001264-PIP01-12-M02
|
Pharmaceutical form(s) |
Implantation suspension
|
Condition(s) / indication(s) |
Treatment of cartilage disorders
|
Route(s) of administration |
Intra-articular use
|
Contact for public enquiries |
CO.DON AG
Tel. +49 30240352330 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|
Compliance procedure number |
EMEA-C-001264-PIP01-12-M02
|
Compliance opinion date |
24/07/2020
|
Compliance outcome |
positive
|